{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:57:45Z","timestamp":1787169465484,"version":"build-2736575974"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,3,27]],"date-time":"2019-03-27T00:00:00Z","timestamp":1553644800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s00417-019-04296-0","type":"journal-article","created":{"date-parts":[[2019,3,27]],"date-time":"2019-03-27T05:09:25Z","timestamp":1553663365000},"page":"1319-1324","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Conservative management of suspicious melanocytic lesions of the iris"],"prefix":"10.1007","volume":"257","author":[{"given":"Monica M.","family":"Oxenreiter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Marie","family":"Lane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Purva","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana K.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelos S.","family":"Gragoudas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,27]]},"reference":[{"key":"4296_CR1","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1136\/bjo.85.7.848","volume":"85","author":"RM Conway","year":"2001","unstructured":"Conway RM, Chua WCT, Qureshi C, Billson FA (2001) Primary iris melanoma: diagnostic features and outcome of conservative surgical treatment. Br J Ophthalmol 85:848\u2013858","journal-title":"Br J Ophthalmol"},{"key":"4296_CR2","doi-asserted-by":"crossref","first-page":"268","DOI":"10.5858\/2008-132-268-IM","volume":"13","author":"E Henderson","year":"2008","unstructured":"Henderson E, Margo CE (2008) Iris melanoma. Arch Pathol Lab Med 13:268\u2013269","journal-title":"Arch Pathol Lab Med"},{"key":"4296_CR3","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.ophtha.2018.05.021","volume":"125","author":"SL Scholz","year":"2018","unstructured":"Scholz SL, Moller I, Reis H et al (2018) Frequent GNAQ, GNA11, and EIF1AX mutations in iris melanoma. Ophthalmology. 125:904\u2013912","journal-title":"Ophthalmology."},{"key":"4296_CR4","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.ophtha.2017.12.022","volume":"125","author":"NM Poppelen van","year":"2018","unstructured":"van Poppelen NM, Vaarwater J, Mudhar HS et al (2018) Genetic background of iris melanomas and iris melanocytic tumors of uncertain malignant potential. Ophthalmology. 125:904\u2013912","journal-title":"Ophthalmology."},{"key":"4296_CR5","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1001\/archophthalmol.2010.166","volume":"128","author":"AM Lane","year":"2010","unstructured":"Lane AM, Egan KM, Kim IK, Gragoudas E (2010) Mortality after diagnosis of small melanocytic lesions of the choroid. Arch Ophthalmol 128:996\u20131000","journal-title":"Arch Ophthalmol"},{"key":"4296_CR6","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/S0161-6420(00)00449-8","volume":"108","author":"CL Shields","year":"2001","unstructured":"Shields CL, Shields JA, Materin M, Gershenbaum E, Singh A, Smith A (2001) Iris melanoma: risk factors for metastasis in 169 consecutive patients. Ophthalmology. 108:172\u2013178","journal-title":"Ophthalmology."},{"key":"4296_CR7","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1001\/archophthalmol.2011.286","volume":"130","author":"S Khan","year":"2012","unstructured":"Khan S, Finger PT, Yu G-P (2012) Clinical and pathologic characteristics of biopsy-proven iris melanoma: a multicenter international study. Arch Ophthalmol 130:57\u201364","journal-title":"Arch Ophthalmol"},{"key":"4296_CR8","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.ophtha.2012.09.042","volume":"120","author":"CL Shields","year":"2013","unstructured":"Shields CL, Kaliki S, Hutchinson A et al (2013) Iris nevus growth into melanoma: analysis of 1611 consecutive eyes. Ophthalmology. 120:766\u2013772","journal-title":"Ophthalmology."},{"key":"4296_CR9","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1016\/S0161-6420(88)33022-8","volume":"95","author":"C Territo","year":"1988","unstructured":"Territo C, Shields CL, Shields JA, Augsburger JJ, Schroeder RP (1988) Natural course of melanocytic tumors of the iris. Ophthalmology. 95:1251\u20131255","journal-title":"Ophthalmology."},{"key":"4296_CR10","doi-asserted-by":"publisher","first-page":"231","DOI":"10.4274\/tjo.66742","volume":"47","author":"MA Eren","year":"2017","unstructured":"Eren MA, Gunduz AK, Gunduz OO (2017) Evaluation of iris melanoma with anterior segment optical coherence tomography. Turk J Ophthalmol 47:231\u2013234","journal-title":"Turk J Ophthalmol"},{"key":"4296_CR11","doi-asserted-by":"publisher","first-page":"123","DOI":"10.4274\/tjo.37431","volume":"46","author":"B Tarlan","year":"2016","unstructured":"Tarlan B, K\u0131ratl\u0131 H (2016) Uveal melanoma: current trends in diagnosis and management. Turk J Ophthalmol 46:123\u2013137","journal-title":"Turk J Ophthalmol"},{"key":"4296_CR12","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1016\/S0161-6420(95)30765-8","volume":"102","author":"JW Harbour","year":"1995","unstructured":"Harbour JW, Augsburger JJ, Eagle RC Jr (1995) Initial management and follow-up of melanocytic iris tumors. Ophthalmology. 102:1987\u20131993","journal-title":"Ophthalmology."},{"key":"4296_CR13","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/j.1442-9071.1990.tb01821.x","volume":"18","author":"DM Workman","year":"1990","unstructured":"Workman DM, Weiner JW (1990) Melanocytic lesions of the iris - a clinicopathological study of 100 cases. Aust N Z J Ophthalmol 18:381\u2013384","journal-title":"Aust N Z J Ophthalmol"},{"key":"4296_CR14","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.ajo.2011.11.004","volume":"153","author":"GP Giuliari","year":"2012","unstructured":"Giuliari GP, Krema H, McGowan HD, Pavlin CJ, Simpson ER (2012) Clinical and ultrasound biomicroscopy features associated with growth in iris melanocytic lesions. Am J Ophthalmol 153:1043\u20131049","journal-title":"Am J Ophthalmol"},{"key":"4296_CR15","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.ajo.2010.09.024","volume":"151","author":"G Giuliari","year":"2011","unstructured":"Giuliari G, McGowan H, Pavlin C, Heathcote J, Simpson E (2011) Ultrasound biomicroscopic imaging of iris melanoma: a clinicopathologic study. Am J Ophthalmol 151:579\u2013585","journal-title":"Am J Ophthalmol"},{"key":"4296_CR16","first-page":"6","volume":"9","author":"J Quinn","year":"2008","unstructured":"Quinn J, Kramer N, McDermott D (2008) Validation of the social security death index (SSDI): an important readily-available outcomes database for researchers. West J Emerg Med 9:6\u20138","journal-title":"West J Emerg Med"},{"key":"4296_CR17","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/oxfordjournals.aje.a116664","volume":"137","author":"EE Calle","year":"1993","unstructured":"Calle EE, Terrell DD (1993) Utility of the National Death Index for ascertainment of mortality among cancer prevention study II participants. Am J Epidemiol 137:235\u2013241","journal-title":"Am J Epidemiol"},{"key":"4296_CR18","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/S1047-2797(01)00285-X","volume":"12","author":"DC Cowper","year":"2002","unstructured":"Cowper DC, Kubal JD, Maynard C, Hynes DM (2002) A primer and comparative review of major US mortality databases. Ann Epidemiol 12:462\u2013468","journal-title":"Ann Epidemiol"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-019-04296-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-019-04296-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-019-04296-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T08:37:03Z","timestamp":1663144623000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-019-04296-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,27]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["4296"],"URL":"https:\/\/doi.org\/10.1007\/s00417-019-04296-0","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,27]]},"assertion":[{"value":"7 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Kim has received research support from Genentech and consulting and research fees from Genentech, Iconic Therapeutics, Allergan, Castle Biosciences, and Alcon. Dr. Gragoudas acts as an advisory\/monitoring board member of Iconic Therapeutics, Aura Biosciences, and Astellas Pharma Inc. Dr. Gragoudas also holds a patent in Valeant Pharmaceuticals. Authors Oxenreiter, Lane, and Jain declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was conducted in accordance with the ethical standards of the Mass Eye and Ear Institutional Review Board that granted an informed consent waiver for this retrospective chart review study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}